UT2 - Master in Continuing Education in Regenerative Biotech Strategy & Translational Longevity (Application & Verification)
Master in Continuing Education in Regenerative Biotech Strategy
& Translational Longevity
Awarded by Universidad Tecnológica Atlántico-Mediterráneo (UTAMED)
Architected by RSIT · Delivered through Sherman Pathways
Program Overview
The Master in Continuing Education in Regenerative Biotech Strategy & Translational Longevity is the inaugural program within RSIT’s Signature Series—the Institute’s highest tier of academic architecture.
This program is designed for professionals who operate at the strategic, translational, regulatory, and governance layers of longevity biotechnology and regenerative innovation. It is non-clinical, non-laboratory, and non-diagnostic by design, focusing instead on systems-level mastery: how longevity science is translated, regulated, funded, governed, and deployed responsibly in real-world environments.
The program is institution-designed, expert-elevated, and governance-aware, built to maintain long-term academic credibility independent of any individual personality.
- Biotech founders and senior executives
- Longevity and regenerative medicine strategists
- Translational science and preclinical program leaders
- Investors, venture analysts, and biotech advisors
- Regulatory, policy, and governance professionals
- Consultants operating in aging-adjacent innovation ecosystems
What Makes This a Signature Series Program?
Institution-Led Academic Architecture. Systems-Level Orientation. Advisory-Backed Rigor.
Unlike expert-centric programs, this Master’s degree is architected and governed by RSIT. Curriculum structure, assessment logic, and progression standards are institutionally defined.
We do not train laboratory execution. We train systems-level understanding of how biotech functions under real constraints—scientific, regulatory, ethical, and financial.
Programs are supported by RSIT’s academic support faculty and a multidisciplinary advisory ecosystem spanning AI, governance, leadership, ethics, and systems design.
The Two-Layer Signature Model
This Master’s program is designed as a durable academic system: a permanent RSIT foundation with an added Signature Chair overlay that increases distinction without creating dependency.
RSIT designs, governs, and quality-assures the academic system behind the Master’s degree—ensuring rigor, consistency, and long-term credibility.
- Curriculum architecture & progression logic
- Assessment & quality assurance (QA)
- Faculty facilitation and academic support
- Governance, compliance posture, and continuity
Master’s Degree Architecture
10 Advanced RSIT Certifications · 60 ECTS Total · Modular & Cumulative
Strategic mastery of the global longevity biotechnology ecosystem, including regenerative innovation models, AI-assisted discovery platforms, translational pipelines, venture structures, and competitive intelligence.
Deep conceptual mastery of the translational journey from discovery through preclinical validation to IND-enabling readiness. Emphasizes risk assessment and translational logic.
Covers ethical frameworks, safety considerations, governance models, and societal risks associated with regenerative medicine, longevity therapeutics, and gene modulation.
Strategic mastery of global regulatory frameworks governing longevity therapeutics, including FDA, EMA, MHRA, PMDA, and international equivalents.
Systems-level analysis of geroprotective and senotherapeutic approaches, including senolytics, senomorphics, autophagy modulation, and mitochondrial therapeutics.
Strategic and technical literacy in AI-driven drug discovery, generative chemistry, predictive toxicology, in-silico modeling, and computational acceleration.
High-level mastery of cellular reprogramming and epigenetic rejuvenation strategies, including safety constraints, tumorigenicity risks, and translational feasibility.
Conceptual mastery of multi-omic biomarkers, aging clocks, surrogate endpoints, and translational readiness scoring—without laboratory measurement.
Strategic understanding of clinical development logic for aging-adjacent therapeutics, including Phase I–III trial architecture, surrogate endpoints, and ethical recruitment.
An integrative framework covering the convergence of biotechnology, artificial intelligence, synthetic biology, automation, and regenerative innovation.
Signature Honors Capstone (Optional)
A Distinction, Not a RequirementThe Signature Honors Capstone is an optional, thesis-level professional project designed for students seeking the highest level of distinction within the Signature Series. It integrates all ten certifications into a single, system-level strategic deliverable that demonstrates mastery beyond course completion.
The capstone framework, evaluation criteria, and excellence thresholds are established at the Signature Series level by a Signature Chair (when appointed), reflecting real-world strategic, translational, and governance expectations.
RSIT faculty and academic support teams facilitate and assess each capstone using the Signature standards to ensure rigor, consistency, and institutional accountability—without dependency on a single individual.
The final submission is designed to be defensible and usable in executive, advisory, investor, or policy contexts—structured as a professional artifact rather than an academic exercise.
Honors candidates receive access to a Signature Chair session series designed to sharpen thesis-level thinking, failure-pattern recognition, and real-world strategic judgment.
- Signature Honors designation (upon successful completion)
- Opt-in listing in a Signature Honors Registry (public professional signal)
- Digital credential / LinkedIn-ready badge (issued by RSIT)
- Portfolio-grade capstone dossier suitable for external defense
Tuition Options & Enrollment
- European “Título Propio” Master’s
- 10 RSIT Certifications (60 ECTS)
- Full academic instruction & assessment
- Modular capstone inside each certification
- Institutional oversight & credibility
Ideal for professionals advancing internally who need recognized Master’s-level depth without a portfolio-grade public signal.
- Everything in Standard Track
- Signature Honors Capstone (+€1,500)
- Signature Chair standards overlay (Chair-defined when appointed)
- Signature session series access
- Formal Signature Honors designation + digital badge
- Portfolio-grade capstone dossier
Best for founders, advisors, consultants, and senior leaders who need proof of systems-level mastery—not just a transcript.
To receive the Master of Continuing Education / Máster de Formación Permanente (Título Propio) from UTAMED, applicants must hold a valid Bachelor’s Degree (or international equivalent). Students without a degree may take the certifications but cannot be awarded the University Master's title.
Standard: 24 months maximum.
Recommended: 12 months (4-6 weeks/module).
Extension: Max 12 months available at surcharge.
NON-REIMBURSABLE / NON-REFUNDABLE
Paying this fee secures priority admission status and initiates your financial aid assessment.
Pathway for Independent Certification Holders
Have you already completed the 10 required RSIT certifications independently? Students who hold all 10 verified certifications may apply to convert their portfolio into the Master of Continuing Education / Máster de Formación Permanente (Título Propio) upon payment of a Degree Conversion & Matriculation Fee (€1,500), subject to academic validation.
*Note: If you wish to also earn the Signature Honors designation, the Signature Honors Capstone requires an additional €1,500 fee.
Contact Admissions to verify eligibility →It is institution-designed academic architecture—enhanced by expertise, built for consequence.
Pairs well with
UT2 - Master in Continuing Education in Regenerative Biotech Strategy & Translational Longevity (Application & Verification)